Late Breaking Abstract - Safety, tolerability and antifibrotic activity of bexotegrast: Phase 2a INTEGRIS-IPF study (NCT04396756)

Wuyts, Wim A, Valenzuela, Claudia, Jenkins, Gisli · Idiopathic interstitial pneumonias · 2023